Astellas Pharma Inc (ALPMY)
10.70
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
Astellas Pharma Price to Book Value: 1.788 for Nov. 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 1.788 |
| November 13, 2024 | 1.794 |
| November 12, 2024 | 1.825 |
| November 11, 2024 | 1.873 |
| November 08, 2024 | 1.866 |
| November 07, 2024 | 1.888 |
| November 06, 2024 | 1.866 |
| November 05, 2024 | 1.905 |
| November 04, 2024 | 1.957 |
| November 01, 2024 | 1.948 |
| October 31, 2024 | 1.952 |
| October 30, 2024 | 2.054 |
| October 29, 2024 | 1.945 |
| October 28, 2024 | 1.884 |
| October 25, 2024 | 1.895 |
| October 24, 2024 | 1.925 |
| October 23, 2024 | 1.912 |
| October 22, 2024 | 1.950 |
| October 21, 2024 | 1.966 |
| October 18, 2024 | 1.96 |
| October 17, 2024 | 1.927 |
| October 16, 2024 | 1.906 |
| October 15, 2024 | 1.916 |
| October 14, 2024 | 1.952 |
| October 11, 2024 | 1.957 |
| Date | Value |
|---|---|
| October 10, 2024 | 1.978 |
| October 09, 2024 | 1.947 |
| October 08, 2024 | 1.958 |
| October 07, 2024 | 1.957 |
| October 04, 2024 | 1.950 |
| October 03, 2024 | 1.938 |
| October 02, 2024 | 1.913 |
| October 01, 2024 | 1.902 |
| September 30, 2024 | 1.913 |
| September 27, 2024 | 2.015 |
| September 26, 2024 | 2.023 |
| September 25, 2024 | 2.028 |
| September 24, 2024 | 2.035 |
| September 23, 2024 | 2.066 |
| September 20, 2024 | 2.052 |
| September 19, 2024 | 2.062 |
| September 18, 2024 | 2.069 |
| September 17, 2024 | 2.020 |
| September 16, 2024 | 2.050 |
| September 13, 2024 | 2.039 |
| September 12, 2024 | 2.117 |
| September 11, 2024 | 2.134 |
| September 10, 2024 | 2.125 |
| September 09, 2024 | 2.146 |
| September 06, 2024 | 2.105 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.577
Minimum
Apr 15 2024
2.868
Maximum
Jun 01 2020
2.282
Average
2.333
Median
Price to Book Value Benchmarks
| Pfizer Inc | 1.522 |
| Takeda Pharmaceutical Co Ltd | 0.8914 |
| Nxera Pharma Co Ltd | 1.689 |
| PeptiDream Inc | 6.033 |
| Healios KK | 6.707 |
Price to Book Value Related Metrics
| PE Ratio | 183.47 |
| PS Ratio | 1.689 |
| Price | 10.70 |
| Earnings Yield | 0.54% |
| Market Cap | 19.15B |
| Operating PE Ratio | 186.91 |
| Normalized PE Ratio | 392.53 |